According to Clovis Oncology's latest financial reports the company's total debt is โฌ0.57 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2021-12-31 | โฌ0.56 B | 7.17% |
2020-12-31 | โฌ0.52 B | -17.55% |
2019-12-31 | โฌ0.63 B | 26.59% |
2018-12-31 | โฌ0.50 B | 114.11% |
2017-12-31 | โฌ0.23 B | -11.94% |
2016-12-31 | โฌ0.26 B | 4.41% |
2015-12-31 | โฌ0.25 B | 8.29% |
2014-12-31 | โฌ0.23 B |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() BioMarin Pharmaceutical BMRN | โฌ0.51 B | -11.56% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | โฌ26.56 B | 4,497.87% | ๐ฌ๐ง UK |
![]() Pfizer PFE | โฌ52.03 B | 8,905.17% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | โฌ44.36 B | 7,577.12% | ๐บ๐ธ USA |
![]() AbbVie ABBV | โฌ59.33 B | 10,168.43% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | โฌ32.69 B | 5,558.94% | ๐บ๐ธ USA |